BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34764678)

  • 1. CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients.
    Lu N; Liu J; Xu M; Liang J; Wang Y; Wu Z; Xing Y; Diao F
    Int J Gen Med; 2021; 14():7647-7657. PubMed ID: 34764678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
    Liu B; Dong Z; Lu Y; Ma J; Ma Z; Wang H
    Evid Based Complement Alternat Med; 2022; 2022():3478861. PubMed ID: 36034941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer.
    Xu Z; Xiang L; Wang R; Xiong Y; Zhou H; Gu H; Wang J; Peng L
    Biomed Res Int; 2021; 2021():8072796. PubMed ID: 34888385
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xie X; Tang Y; Sheng J; Shu P; Zhu X; Cai X; Zhao C; Wang L; Huang X
    Front Cell Dev Biol; 2021; 9():761758. PubMed ID: 34746153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between tumor mutation burden and immune infiltration in ovarian cancer.
    Fan S; Gao X; Qin Q; Li H; Yuan Z; Zhao S
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107126. PubMed ID: 33189611
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Sun Y; Li L; Yao W; Liu X; Yang Y; Ma B; Xue D
    Front Genet; 2021; 12():762160. PubMed ID: 34795697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma.
    Ying K; Zou L; Wang D; Wang R; Qian J
    Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37904553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
    Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
    Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLG Gene Mutation Up-regulates the Abnormal Tumor Immune Response and Promotes the Progression of Prostate Cancer.
    Zhang P; An Z; Sun C; Xu Y; Zhang Z
    Curr Pharm Biotechnol; 2022; 23(14):1658-1670. PubMed ID: 35422210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
    Zhang F; Li X; Chen H; Guo J; Xiong Z; Yin S; Jin L; Chen X; Luo D; Tang H; Mao C; Lian L
    Front Med (Lausanne); 2022; 9():836892. PubMed ID: 35211490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
    Zhu G; Pei L; Li Y; Gou X
    Aging (Albany NY); 2020 Feb; 12(3):2132-2141. PubMed ID: 32012118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.
    Kang K; Xie F; Mao J; Bai Y; Wang X
    Front Oncol; 2020; 10():573141. PubMed ID: 33072607
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of
    Wang Z; Hou H; Zhang H; Duan X; Li L; Meng L
    Am J Transl Res; 2022; 14(2):849-862. PubMed ID: 35273689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of KDM6A mutation in bladder cancer immune escape.
    Chen X; Lin X; Pang G; Deng J; Xie Q; Zhang Z
    BMC Cancer; 2021 May; 21(1):635. PubMed ID: 34051747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD8
    Li L; Chen D; Luo X; Wang Z; Yu H; Gao W; Zhong W
    Front Genet; 2022; 13():860161. PubMed ID: 35711935
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer.
    Bi F; Chen Y; Yang Q
    Cancer Cell Int; 2020; 20():373. PubMed ID: 32774167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients.
    Cui S; Feng J; Tang X; Lou S; Guo W; Xiao X; Li S; Chen X; Huan Y; Zhou Y; Xiao L
    Eur J Med Res; 2023 Feb; 28(1):90. PubMed ID: 36805828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer.
    Guo Z; Yan X; Song C; Wang Q; Wang Y; Liu XP; Huang J; Li S; Hu W
    Front Oncol; 2021; 11():603660. PubMed ID: 33816234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.